158 related articles for article (PubMed ID: 10777489)
1. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Domina AM; Smith JH; Craig RW
J Biol Chem; 2000 Jul; 275(28):21688-94. PubMed ID: 10777489
[TBL] [Abstract][Full Text] [Related]
2. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW
Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487
[TBL] [Abstract][Full Text] [Related]
3. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW
Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965
[TBL] [Abstract][Full Text] [Related]
4. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
Vrana JA; Cleaveland ES; Eastman A; Craig RW
Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
[TBL] [Abstract][Full Text] [Related]
5. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation.
Townsend KJ; Zhou P; Qian L; Bieszczad CK; Lowrey CH; Yen A; Craig RW
J Biol Chem; 1999 Jan; 274(3):1801-13. PubMed ID: 9880563
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis.
Vantieghem A; Xu Y; Assefa Z; Piette J; Vandenheede JR; Merlevede W; De Witte PA; Agostinis P
J Biol Chem; 2002 Oct; 277(40):37718-31. PubMed ID: 12101183
[TBL] [Abstract][Full Text] [Related]
7. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.
Nifoussi SK; Ratcliffe NR; Ornstein DL; Kasof G; Strack S; Craig RW
J Biol Chem; 2014 Aug; 289(32):21950-9. PubMed ID: 24939844
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.
Ling YH; Tornos C; Perez-Soler R
J Biol Chem; 1998 Jul; 273(30):18984-91. PubMed ID: 9668078
[TBL] [Abstract][Full Text] [Related]
10. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.
McDaid HM; Horwitz SB
Mol Pharmacol; 2001 Aug; 60(2):290-301. PubMed ID: 11455016
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
[TBL] [Abstract][Full Text] [Related]
12. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.
Yang CP; Horwitz SB
Cancer Res; 2000 Sep; 60(18):5171-8. PubMed ID: 11016645
[TBL] [Abstract][Full Text] [Related]
13. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
[TBL] [Abstract][Full Text] [Related]
14. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
16. Novel role for JNK as a stress-activated Bcl2 kinase.
Deng X; Xiao L; Lang W; Gao F; Ruvolo P; May WS
J Biol Chem; 2001 Jun; 276(26):23681-8. PubMed ID: 11323415
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
18. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
Yamamoto K; Ichijo H; Korsmeyer SJ
Mol Cell Biol; 1999 Dec; 19(12):8469-78. PubMed ID: 10567572
[TBL] [Abstract][Full Text] [Related]
19. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells.
Blagosklonny MV; Chuman Y; Bergan RC; Fojo T
Leukemia; 1999 Jul; 13(7):1028-36. PubMed ID: 10400418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]